David Baltimore - Amgen Insider

Amgen Inc -- USA Stock  

USD 186.11  0.18  0.10%

Independent Director

Dr. David Baltimore, Ph.D., is an Independent Director of Amgen Inc. David Baltimore is President Emeritus and Robert Andrews Millikan Professor of Biology at the California Institute of Technology, or Caltech. He received the Nobel Prize in Medicine as a corecipient in 1975. Dr. Baltimore was a director of Regulus Therapeutics Inc., a biopharmaceutical company, since 2007, serving on its Compensation Committee and chairing its Nominating and Governance Committee, and is a member of its scientific advisory board
Age: 78  Director Since 1999  Ph.D    
805 447-1010  www.amgen.com
Baltimore has also been a member of the board of directors of Immune Design Corporationrationration, a clinicalstage immunotherapy company, since 2008, chairing its Nominating and Governance Committee, and is a member of its scientific advisory board. He was a director of BB Biotech, AG, a Swiss investment company, from 1994 to March 2011 and served as a director of MedImmune, Inc., a privatelyheld antibody formulation company, from 2003 until its acquisition by AstraZeneca plc, a pharmaceutical and biotechnology company, in 2007. In 2008, Dr. Baltimore became a founder of Calimmune, Inc., a privatelyheld clinicalstage gene therapy company, and served as Chairman of the board of directors until November 2015.

David Baltimore Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Alan GarberVertex Pharmaceuticals Incorpor
2017
Fred WeissAllergan plc
2013
Ronald RittenmeyerQuintiles IMS Holdings Inc
2016
James FasanoQuintiles IMS Holdings Inc
2016
Jill SmithEndo International plc
2012
Haiyuan LoQuintiles IMS Holdings Inc
2015
Sally BlountAbbott Laboratories
2011
Alice SchwartzBio Rad Laboratories Inc
1967
Joseph BoccuziAllergan plc
2017
Bruce SachsVertex Pharmaceuticals Incorpor
2017
Samuel ScottAbbott Laboratories
2007
William YoungVertex Pharmaceuticals Incorpor
2014
Elaine UllianVertex Pharmaceuticals Incorpor
2011
Arthur HigginsEndo International plc
2013
Joel McCombBio Rad Laboratories Inc
2014
James BloemAllergan plc
2013
David AltshulerVertex Pharmaceuticals Incorpor
2015
Robert AlpernAbbott Laboratories
2008
Nancy HutsonEndo International plc
2009
Ari BousbibQuintiles IMS Holdings Inc
2016
Christopher CoughlinAllergan plc
2016

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators